| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/22/2006 | EP1635776A1 Lipidic protein-transfer systems and cosmetic/dermatological use thereof |
| 03/22/2006 | EP1635773A2 Combination therapy for the treatment of hypertension |
| 03/22/2006 | EP1635766A2 Lactoferrin as an adjuvant in cancer vaccines |
| 03/22/2006 | EP1635764A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | EP1635651A1 Methods for hyperthyroidism in a cat and composition comprising limited iodine |
| 03/22/2006 | EP1601324A4 Hemostatic compositions and methods |
| 03/22/2006 | EP1597278A4 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 03/22/2006 | EP1448219B1 Antiglaucomatous agent and use thereof |
| 03/22/2006 | EP1414524B1 Treatment of hair follicle with neurokinin 1 receptor antagonists |
| 03/22/2006 | EP1328253B1 Administration of a thiol-based chemoprotectant compound |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP1297016B1 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 03/22/2006 | EP1221963A4 Methods of inhibiting osteoclastogenesis |
| 03/22/2006 | EP1221847A4 Methods of enhancing chemotherapy |
| 03/22/2006 | EP1179008B1 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/22/2006 | EP1149171B1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1093818B1 Powdery preparation for mucosal administration containing polymeric medicine |
| 03/22/2006 | EP1075673A4 Methods of determining protein activity levels using gene expression profiles |
| 03/22/2006 | EP1011695B1 Use of neurotoxin therapy for treatment of prostate disorders |
| 03/22/2006 | EP1008603B1 Soluble polypeptides consisting on the first coiled coil domain of human and mouse epimorphin. |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0972520B9 Freeze-dried composition of bone morphogenetic protein human mp52 |
| 03/22/2006 | EP0948356B1 Agent for identifying and treating metastasizing tumours |
| 03/22/2006 | EP0933379B1 Novel peptide derivatives having thiazolyl-alanine residue |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0694044B1 Method and product for regulating cell responsiveness to external signals |
| 03/22/2006 | CN1751251A Biomedical devices with antimicrobial coatings |
| 03/22/2006 | CN1751122A Fusion proteins of interferon alpha muteins with improved properties |
| 03/22/2006 | CN1750844A Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 03/22/2006 | CN1750842A Analogues of GLP-1 |
| 03/22/2006 | CN1750841A CLK-peptide and SLK-peptide |
| 03/22/2006 | CN1750840A Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 03/22/2006 | CN1750809A Fast dissolving orally consumable films containing pharmaceutically active agents |
| 03/22/2006 | CN1749277A Heat shock protein 65-human SARS coronary virus epitope antigen recombinant fusion protein (HSP65SARS/3CL161-264) |
| 03/22/2006 | CN1749276A Heat shock protein 65-epithelial cell growth factor receptor 2 fusion protein (HSP65-HER2) |
| 03/22/2006 | CN1748790A Asparaginase injection its preparing method and use |
| 03/22/2006 | CN1748789A Medicine for reducing blood fat and its preparing method |
| 03/22/2006 | CN1748788A Recombinant human interferon alpha 26 injection of prefilled injector package |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1748786A Lactic streptostacin lozenge and its preparing method |
| 03/22/2006 | CN1748785A Water solution preparation of reducing type glutathione, its preparing method and use |
| 03/22/2006 | CN1748784A Process for producing ampeptide element |
| 03/22/2006 | CN1246462C Modified vitamin K-dependent polypeptides |
| 03/22/2006 | CN1246457C Human TSC403 gene and human ING1L gene |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246337C Novel TNFR-Fc fusion protein |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246047C A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/22/2006 | CN1246040C Process to make a sustained release formulation |
| 03/22/2006 | CN1246037C Novel use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 03/22/2006 | CN1246036C Process for preparing glycopeptide phosphonate derivatives |
| 03/22/2006 | CN1246035C Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 03/22/2006 | CN1245967C Use of compound in making medicine |
| 03/22/2006 | CN1245960C Non-oral preparation having three-layer structure |
| 03/22/2006 | CN1245955C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/21/2006 | USRE39034 synthetic polypeptides used to control semen binding to oocytes; fertility and/or antifertility agents |
| 03/21/2006 | US7015371 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 03/21/2006 | US7015316 persephin is a member of the GDNF-Neurturin family of growth factors; Glial-derived neurotrophic factor (GDNF); promotes survival of mesencephalic neuronal cells; nucleic acids of given sequences |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015313 use as a diagnostic agent or a carrier protein conjugated to various anti-cancer drugs owing to its ability to specifically recognize N-glycolylneuraminic acid; antiproliferative agent; called lectin PPA (Philyra pisum agglutinin) |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015307 Process for purifying glycopeptide phosphonate derivatives |
| 03/21/2006 | US7015306 Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes |
| 03/21/2006 | US7015305 Process for preparing glycopeptide derivatives |
| 03/21/2006 | US7015199 Treatment of psoriasis through down-regulation of the EGF-receptor with topically-applied EGF |
| 03/21/2006 | US7015198 Materials for soft tissue augmentation and methods of making and using same |
| 03/21/2006 | US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants |
| 03/21/2006 | US7015195 Treatment of bone disorders with skeletal anabolic drugs |
| 03/21/2006 | US7015194 Mixture of factor vii and btissue factor pathway inhibitor; blood coagulation |
| 03/21/2006 | US7015193 Compositions and methods to control bleeding |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015040 Intravascular delivery of nucleic acid |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7014869 Rapid dehydration of proteins |
| 03/21/2006 | US7014866 High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same |
| 03/21/2006 | US7014863 Additive for an animal feed |
| 03/21/2006 | US7014855 inducing an immune response against a peptide component of an amyloid deposit; active administration of an immunogen or passive administration of an antibody or an active fragment or derivative of the antibody; Alzheimer's disease |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014852 Alkaline phosphatase to induce weight loss or to reduce weight gain |
| 03/21/2006 | US7014851 Process for inhibiting platelet aggregation |
| 03/21/2006 | US7014850 Nasal spray for treating streptococcal infections |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | CA2443314C Method of imaging cell death in vivo |
| 03/21/2006 | CA2266743C Adenoviral vectors for mutants of human interleukin 6 (hil-6) with hil-6 antagonist activity, pharmaceutical compositions therewith and their uses |
| 03/21/2006 | CA2191406C Process for removing aromatic compounds from product-containing solutions |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/17/2006 | CA2477867A1 Peptides, dna's, rna's, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 03/16/2006 | WO2006029411A2 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| 03/16/2006 | WO2006029406A2 Methods for treating bone tumors using bone morphogenic proteins |
| 03/16/2006 | WO2006029371A2 Neuromedin u 2 receptor agonists and uses thereof |
| 03/16/2006 | WO2006029343A2 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 03/16/2006 | WO2006029287A1 Use of a botulinum toxin for treating a buttock deformity |
| 03/16/2006 | WO2006029173A2 Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12 |